Use of tranexamic acid in traumatic injury emergencies reduces mortality, with no significant increase in problematic vascular occlusive events. This systematic review and bias-adjusted meta-analysis ...
The use of tranexamic acid (TXA) in patients undergoing oncology and other major noncardiac surgeries reduces the administration of red blood cell (RBC) transfusions across patient and surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results